Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,024 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas.
Chang K, Pastan I, Willingham MC. Chang K, et al. Int J Cancer. 1992 Jun 19;51(4):548-54. doi: 10.1002/ijc.2910510408. Int J Cancer. 1992. PMID: 1351045
Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes.
Hall MD, Telma KA, Chang KE, Lee TD, Madigan JP, Lloyd JR, Goldlust IS, Hoeschele JD, Gottesman MM. Hall MD, et al. Cancer Res. 2014 Jul 15;74(14):3913-22. doi: 10.1158/0008-5472.CAN-14-0247. Epub 2014 May 8. Cancer Res. 2014. PMID: 24812268 Free PMC article.
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J, Wei BR, Chang KE, Shukla S, Ambudkar SV, Simpson RM, Gottesman MM, Hall MD. Bakhsheshian J, et al. Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20801-6. doi: 10.1073/pnas.1312159110. Epub 2013 Dec 2. Proc Natl Acad Sci U S A. 2013. PMID: 24297888 Free PMC article.
The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.
Chang KE, Wei BR, Madigan JP, Hall MD, Simpson RM, Zhuang Z, Gottesman MM. Chang KE, et al. Mol Cancer Ther. 2015 Jan;14(1):90-100. doi: 10.1158/1535-7163.MCT-14-0496. Epub 2014 Nov 5. Mol Cancer Ther. 2015. PMID: 25376608 Free PMC article.
H⁺-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma.
Lee DG, Lee JH, Choi BK, Kim MJ, Kim SM, Kim KS, Chang K, Park SH, Bae YS, Kwon BS. Lee DG, et al. Among authors: chang k. Curr Cancer Drug Targets. 2011 Oct;11(8):966-75. doi: 10.2174/156800911797264752. Curr Cancer Drug Targets. 2011. PMID: 21861841
Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.
Chang K, Pastan I. Chang K, et al. Int J Cancer. 1994 Apr 1;57(1):90-7. doi: 10.1002/ijc.2910570117. Int J Cancer. 1994. PMID: 8150545
Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
Chang K, Pastan I. Chang K, et al. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):136-40. doi: 10.1073/pnas.93.1.136. Proc Natl Acad Sci U S A. 1996. PMID: 8552591 Free PMC article.
Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium.
Chang K, Pastan I, Willingham MC. Chang K, et al. Int J Cancer. 1992 Feb 1;50(3):373-81. doi: 10.1002/ijc.2910500308. Int J Cancer. 1992. PMID: 1735605
Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium.
Chang K, Pai LH, Batra JK, Pastan I, Willingham MC. Chang K, et al. Cancer Res. 1992 Jan 1;52(1):181-6. Cancer Res. 1992. PMID: 1727378
Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors.
Chang K, Ding I, Kern FG, Willingham MC. Chang K, et al. J Histochem Cytochem. 1991 Sep;39(9):1281-7. doi: 10.1177/39.9.1680897. J Histochem Cytochem. 1991. PMID: 1680897
8,024 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback